SP

Savita Pahwa

Active Director Director DIN 08720975
DIN 08720975 First appointment Jul 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Savita Pahwa

Data last updated:

Savita Pahwa is a Director at The Ayurvedic Pharmaceuticals Company Limited (since 2020). The company operates in Pharma. The Ayurvedic Pharmaceuticals Company Limited reported revenue of ₹74.8 Lakh (FY 2025).

DIN 08720975
Primary Designation Director
Industry Pharma
First Appointment 17 Jul 2020
Oldest Company Age 121 yrs
Largest company The Ayurvedic Pharmaceuticals Company Limited · ₹74.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jul 20201905₹74.8 Lakh (FY 2025)Active

Board colleagues of Savita Pahwa

Directorship timeline

Open interactive timeline →
The Ayurvedic Pharmaceuticals Company Limited
Premium access

Shareholding and investment profile for Savita Pahwa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Savita Pahwa

Savita Pahwa currently holds 1 directorship: The Ayurvedic Pharmaceuticals Company Limited (Director, since 17 Jul 2020, revenue ₹74.8 Lakh (FY 2025)).

Savita Pahwa was first appointed on 17 Jul 2020 as Director at The Ayurvedic Pharmaceuticals Company Limited.

The current boards of Savita Pahwa's companies include Ashok Kumar Pahwa (The Ayurvedic Pharmaceuticals Company Limited), Kaushal Pahwa (The Ayurvedic Pharmaceuticals Company Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available